BrightHeart, a provider of artificial intelligence (AI) solutions for pediatric cardiology and obstetrics, recently announced it has received 510(k) clearance from the U.S. Food and Drug ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
May 19, 2025 — Gradient Denervation Technologies recently announced the company’s pulmonary denervation system has ...
BrightHeart, a provider of artificial intelligence (AI) solutions for pediatric cardiology and obstetrics, recently ...
The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician ...
May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the ...
April 28, 2025 — The Society of Thoracic Surgeons (STS) has launched its latest surgical risk calculator designed for ...
April 17, 2025 — Adults younger than 50 years of age had more than double the risk of having a stroke from migraine or ...

Cardiology practices face mounting financial pressures — rising operational costs, declining reimbursements, and complex ...
April 9, 2025 — Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released ...
March 31, 2025 -— BioCardia, Inc. recently announced two-year outcomes from the double-blind randomized placebo ...
March 30, 2025 — Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data ...
March 31, 2025 — AGEPHA Pharma USA, LLC, has highlighted clinical data that provides new information about how low-dose ...
March 17, 2025 — Bayer recently announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental new ...
March 25, 2025 — Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive ...
March 17, 2025 — Being born with a heart defect may be associated with an increased cancer risk for babies and their ...
Mar. 10, 2025-- Corcept Therapeutics Inc., a commercial-stage company engaged in the discovery and development of ...